Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties (Q37828444)

24 August 2017

1 reference

title

Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties (English)

1 reference

24 August 2017

0 references

0 references

cardiovascular disease

1 reference

Federico Cacciapuoti

1

1 reference

24 August 2017

publication date

1 July 2011

1 reference

Journal of Thrombosis and Thrombolysis

24 August 2017

published in

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

82-88

1 reference

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine and dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

21 January 2018

Homocysteine metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Smoking and plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Induction of oxidative stress by homocyst(e)ine impairs endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Factors associated with the steep increase in late-midlife stroke occurrence among US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

An association between plasma homocysteine concentrations and ischemic stroke in elderly Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine and internal carotid artery occlusion in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Folate therapy and in-stent restenosis after coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

DNA methylation as a biomarker for cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Hyperhomocysteinemia, DNA methylation and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Homocysteine and hypomethylation. A novel link to vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0550-4

Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation

21 January 2018

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

12 December 2020

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial

1 reference

12 December 2020

Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients

1 reference

12 December 2020

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals

1 reference

12 December 2020

An alternative view of homocysteine

1 reference

12 December 2020

Homocysteine and thrombotic disease.

1 reference

12 December 2020

Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.

1 reference

12 December 2020

Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

1 reference

12 December 2020

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

1 reference

12 December 2020

Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations

1 reference

12 December 2020

Elevation in S-Adenosylhomocysteine and DNA Hypomethylation: Potential Epigenetic Mechanism for Homocysteine-Related Pathology

1 reference

12 December 2020

Homocysteine and atherothrombosis

1 reference

12 December 2020

10.1007/S11239-011-0550-4

Identifiers

DOI

1 reference

24 August 2017

1 reference